LifeStance Health (LFST) Capital Expenditures (2020 - 2026)

LifeStance Health has disclosed Capital Expenditures across 7 years of filings, most recently posting $10.8 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 50.21% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $39.7 million (up 68.11% YoY), while the FY2025 annual figure was $36.1 million, up 67.51% from the prior year.
• Capital Expenditures eased to $10.8 million in Q1 2026, from $10.9 million in the prior quarter.
• Over the last five years, Capital Expenditures for LFST reached as high as $27.9 million in Q1 2022 and fell as low as $5.1 million in Q3 2024.
• The 5-year median for Capital Expenditures is $10.3 million (2025), against an average of $11.1 million.
• The widest YoY moves for Capital Expenditures: up 151.87% in 2022, down 73.15% in 2022.
• A 5-year view of Capital Expenditures shows it stood at $10.4 million in 2022, then rose by 9.92% to $11.4 million in 2023, then plunged by 44.8% to $6.3 million in 2024, then jumped by 73.16% to $10.9 million in 2025, then retreated by 1.32% to $10.8 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $10.8 million, $10.9 million, and $10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.